Saltar al contenido principal

R&D Operations

[Janssen] R&D, Clinical Research Associate(CRA)/Site Manager, Global Clinical Operation Japan (Tokyo)

  • Título [Janssen] R&D, Clinical Research Associate(CRA)/Site Manager, Global Clinical Operation Japan (Tokyo)
  • Función R&D Operations
  • Sub función Clinical Trial Project Management
  • Categoría Analyst, Clinical Trial Project Management (P4 - E24)
  • Ubicación Chiyoda, Tokyo-To, Japan
  • Publicado
  • Identificación requerida (Req ID) 2306147331W
Aplicar Ahora










・その他、社内のImprovement activity / Task force teamへの参加


Position Summary:

A Site Manager I in Early Development & Clinical Pharmacology (ED&CP) serves as a primary contact point between the sponsor and the investigational site (both commercial and hospital) for the conduct of early development and/or clinical pharmacology studies. A Site Manager I is assigned to trial sites ensuring inspection readiness through compliance with the clinical research protocol, company's Standard Operating Procedures (SOP), codes of Good Clinical Practice (GCP), Health Care Compliance requirements (HCC), applicable regulations and guidelines from start-up through data-base lock. Responsibilities include site assessments, pre-trial assessments, site selection, site initiation, subject recruitment and retention, monitoring and close-out. Partners with the Clinical Trial Assistant (CTA), Trial Manager (TM) and Global Trial Leader (GTL) to ensure overall site management while performing trial related activities for assigned protocols. A Site Manager I may contribute to process improvement and training.

Principal Responsibilities:

1. Participates in site assessments, conducts pre-trial site assessment visits and/or participates to study feasibility assessments, providing recommendation from local area about site/investigator selection in collaboration with the trial team 

2. Acts as primary contact for assigned sites for specific ED&CP trials and works closely with TM and trial central team regarding study progress and issue resolution.

3. Attends/participates in investigator meetings as needed.

4. Responsible for executing activities within site initiation and start-up, site monitoring, site management and site/study close-out per internal SOPs, other procedural documents and policies.

5. Ensures site staff have current GCP and necessary protocol, compound and systems training to conduct the clinical trial. Complete retraining when needed. Ensure training records are filed at sites and sponsor level.

6. Contributes to site level recruitment strategy and contingency planning and implementation in partnership with other functional areas to achieve clinical research target.

7. Ensures site study supplies (such as Non-IP, lab kits, etc.) are adequate for trial conduct.

8. In collaboration with Site Investigational Product Specialist (SIPS) and Pharmacy Investigational Product Specialist (PIPS), ensures that clinical drug supplies are appropriately handled, administered and stored. Ensure strict adherence to investigational product preparation and administration guidelines. Ensures clinical drug supplies are appropriately inventoried, accounted and returned as applicable including maintenance of accurate and complete documentation.

9. Ensures site staff complete the data entry and resolve queries within expected timelines. Set up plan to improve data entry in collaboration with TM when needed.

10. Ensures accuracy, validity and completeness of data collected at trial sites. Ensure appropriate measures are in place for maintenance of the blind when applicable

11. Ensures that all Adverse Events (AEs)/Serious Adverse events (SAEs)/Product Quality Complaints (PQC) are reported within the required reporting timelines and documented as appropriate. For AEs/SAEs, ensure that they are consistent with all data collected and with the information in the source documents.

12. Maintains complete, accurate and timely data and essential documents in systems utilized for trial management.

13. Fully documents trial related activities with respect to study monitoring. Writes visit reports and address follow-up letters to investigators within procedural timelines. Responsible for documentation and escalation of major deviations and issues to appropriate stakeholders. Ensures timely corrective actions are completed and documented.

14. Reviews investigator site file for completeness and ensures archiving retention requirements, including storage in a secure area at all times.

15. Collaborates with TM for documenting and communicating site/study progress and issues to trial central team.

16. Attends regularly scheduled team meetings and trainings.

17. Complies with relevant training requirements. Acts as local expert in assigned protocols. Develops sufficient therapeutic area and early development knowledge to support roles and responsibilities. Works across therapeutic areas dependent upon ED&CP business needs.

18. Works closely with TM to ensure Corrective Action Preventive Action (CAPA) is completed for QA site audits or Inspection and for quality issues identified at the site during routine monitoring and other visit types, e.g., On Site Quality Monitoring visit (OSQMV).

19. Prepares trial sites for close out, conduct final close out visit.

20. May review and manage site specific informed consent forms in accordance with GCO SOPs, procedural documents and applicable regulations.

21. May participate in the HA and IEC/IRB submission and notification processes as required/appropriate.

22. Tracks costs at site level and ensure payments are made, if applicable or collaborates with C&G in charge of site payments.

23. Establishes and maintains good working relationships with internal and external stakeholders, in particular investigators, trial coordinators, other site staff and key contacts in Early Development and/or Clinical Pharmacology.

24. Coordinates site level lessons learned activities.

25. May contribute to process improvement and training


Principal Relationships:

Primary Reporting Structure: Reports to Functional Manager (FM).

Primary interfaces: FM, CTAs, TMs, SMs. SIPS, PIPS, GTLs, Study Responsible Physicians (SRPs), Quality and Compliance Manager/Specialist, Local Safety Officer

Other Internal Interfaces: C&Gs, GPLs, TA representatives, Integrated Data Analytics and Reporting (IDAR), Bioresearch Quality and Compliance (BRQC), ED&CP Head/US ED&CP head, ED&CP Business Operations & Quality Leader and others as required

External Interfaces: Investigational Site Staff and others as required





・Phase2もしくはPhase3の開発実務経験 (医師主導治験や臨床研究は含まない。抗がん剤の場合はPhase1も含む)

・Global Process(FDAやEMAのRequirement、ICH GCPに則ったプロセス≒国内および海外での申請を目的とした国際共同治験)に基づく治験実務担当経験


・単独でSite Initiation phase(合意~Site open)を2つの異なる試験もしくは5施設以上で経験していること

・Issue managementに関する基礎知識を有し、それに基づく実務経験


・英語での読み書きができる(目安としてTOEIC 650点以上)






・医学、薬学、生物学系大学 学部卒業以上











外資系企業でのCRA担当、あるいはGlobal Studyへの参画経験









   Site initiation phase(合意~Site open(組み入れ可能))

   Conduct(Enrollment) phase(FPI~LPI)

Ex.) Site initiation phase:4施設、多発性骨髄腫、Ph1、6ヶ月




Education and Experience Requirements:

A minimum of a BA or BS degree in Life Sciences, Nursing or related scientific field (or equivalent experience) is required.

A minimum of 1 year of clinical trial monitoring experience is preferred, however, other relevant experiences and skills may be considered by the hiring manager when considering the candidate’s eligibility. Experience in monitoring ED&CP studies is preferred.

Specific therapeutic area experience/knowledge may be required.

Good working knowledge of ICH-GCP, company standard operating procedures, local laws and regulations, assigned protocols and associated protocol specific procedures including monitoring guidelines.

Good IT skills in appropriate software and company systems.

Willingness to travel with occasional/regular overnight stay away from home depending on the region.

Proficient in speaking and writing the country language and English. Good written and oral communication skills.

Flexible mindset and ability to work at a fast pace within small exploratory international study teams in a fast-changing environment.

Ability to work on multiple trials in parallel in different disease areas


Johnson & Johnson Family of Companies in Japan strongly recommends prospective employees to complete the COVID-19 vaccination before or as soon as after joining our company to prevent the spread of infection among our employees and people around them as well as our customers and the community we serve, and to ensure our responsibilities are sustainably fulfilled as a healthcare company (except for those who cannot vaccinated with underlying medical conditions and other circumstances).  


Únete a nuestro Global Talent Hub

Echa un vistazo a J&J.
Partidas de trabajo personalizadas.
Noticias para ti.